Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...

Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for Moleculin Biotech (NasdaqCM:MBRX) from Hold to ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Burning Rock Biotech Limited’s BNR share price has dipped by 12.36%, which has investors questioning if this is right time to ...

The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...

Fintel reports that on March 18, 2025, Citizens Capital Markets upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) ...

Truist Securities announced today that Danielle Brill has joined the firm as managing director, strengthening its equity research coverage in the biotechnology sector. Brill is the latest addition to ...

No change in the last quarter. Sana Biotechnology Background Information (This description is provided by the company.) Sana Biotechnology, Inc. is focused on creating and delivering engineered ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Wednesday, April 2nd, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.50-$8.50 per share. The ...

Krystal Biotech Background Information (This description is provided by the company.) Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy ...

DNA testing pioneer 23andMe filed for bankruptcy — sparking fresh concerns about safeguarding the personal data of the ...